• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Return on investment of the electronic vaccine intelligence network in India.印度电子疫苗智能网络的投资回报。
Hum Vaccin Immunother. 2022 Dec 31;18(1):2009289. doi: 10.1080/21645515.2021.2009289. Epub 2021 Dec 14.
2
Programmatic assessment of electronic Vaccine Intelligence Network (eVIN).电子疫苗智能网络(eVIN)的程序化评估。
PLoS One. 2020 Nov 5;15(11):e0241369. doi: 10.1371/journal.pone.0241369. eCollection 2020.
3
Addressing Immunization Inequity-What Have the International Community and India Learned over 35 Years?应对免疫接种不平等问题——国际社会和印度在35年中学到了什么?
Vaccines (Basel). 2023 Apr 4;11(4):790. doi: 10.3390/vaccines11040790.
4
Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries.在低收入和中低收入国家引进和提供人乳头瘤病毒疫苗的成本:为全球疫苗免疫联盟关于向各国提供引进资助的政策提供的投入
PLoS One. 2014 Jun 26;9(6):e101114. doi: 10.1371/journal.pone.0101114. eCollection 2014.
5
Estimating the economic impact of pneumococcal conjugate, Haemophilus influenzae type b and rotavirus vaccines in India: National and state-level analyses.估算肺炎球菌结合疫苗、流感嗜血杆菌疫苗和轮状病毒疫苗在印度的经济影响:国家和邦级分析。
Vaccine. 2019 Dec 10;37(52):7547-7559. doi: 10.1016/j.vaccine.2019.09.084. Epub 2019 Oct 10.
6
Economic evaluation of Japanese encephalitis vaccination programme in Uttar Pradesh, India: a cost-benefit study.印度北方邦日本脑炎疫苗接种计划的经济评估:一项成本效益研究。
J Vector Borne Dis. 2014 Mar;51(1):47-52.
7
Cost-effectiveness of human papillomavirus vaccination for adolescent girls in Punjab state: Implications for India's universal immunization program.在旁遮普邦为少女接种人乳头瘤病毒疫苗的成本效益:对印度普及免疫计划的影响。
Cancer. 2017 Sep 1;123(17):3253-3260. doi: 10.1002/cncr.30734. Epub 2017 May 4.
8
Budget impact of polio immunization strategy for India: introduction of one dose of inactivated poliomyelitis vaccine and reductions in supplemental polio immunization.印度脊髓灰质炎免疫策略的预算影响:引入一剂灭活脊髓灰质炎疫苗和减少补充脊髓灰质炎免疫。
Public Health. 2017 Jan;142:31-38. doi: 10.1016/j.puhe.2016.10.016. Epub 2016 Nov 17.
9
Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program.投资回报率:对美国公共资助计划生育项目的效益和成本节约情况进行更全面的评估。
Milbank Q. 2014 Dec;92(4):696-749. doi: 10.1111/1468-0009.12080. Epub 2014 Oct 15.
10
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30.免疫接种预防 94 个中低收入国家 10 种病原体的投资回报:2011-2030 年。
Health Aff (Millwood). 2020 Aug;39(8):1343-1353. doi: 10.1377/hlthaff.2020.00103.

引用本文的文献

1
Vaccine-Preventable Diseases in Pediatric Age Group in India: Recent Resurgence, Implications and Solutions.印度儿童年龄组中可通过疫苗预防的疾病:近期的再度流行、影响及解决方案
Indian J Pediatr. 2025 Apr 25. doi: 10.1007/s12098-025-05531-9.
2
Typhoid conjugate vaccine implementation in India: A review of supportive evidence.印度伤寒结合疫苗的实施:支持性证据综述
Vaccine X. 2024 Oct 1;21:100568. doi: 10.1016/j.jvacx.2024.100568. eCollection 2024 Dec.
3
Developing a roadmap to reach and sustain 90% full immunization coverage through a cross-sectoral system strengthening strategy in Bihar, India.制定路线图,通过跨部门的系统强化战略,在印度比哈尔邦实现并维持 90%的完全免疫接种覆盖率。
BMC Health Serv Res. 2024 Aug 14;24(1):933. doi: 10.1186/s12913-024-11380-7.
4
An Equity Analysis of Zero-Dose Children in India Using the National Family Health Survey Data: Status, Challenges, and Next Steps.利用全国家庭健康调查数据对印度零剂量儿童进行的公平性分析:现状、挑战及下一步措施
Cureus. 2023 Feb 24;15(2):e35404. doi: 10.7759/cureus.35404. eCollection 2023 Feb.
5
Multi-dose vials versus single-dose vials for vaccination: perspectives from lower-middle income countries.多剂量小瓶与单剂量小瓶用于疫苗接种:来自中低收入国家的观点。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2059310. doi: 10.1080/21645515.2022.2059310. Epub 2022 Apr 13.

本文引用的文献

1
Programmatic assessment of electronic Vaccine Intelligence Network (eVIN).电子疫苗智能网络(eVIN)的程序化评估。
PLoS One. 2020 Nov 5;15(11):e0241369. doi: 10.1371/journal.pone.0241369. eCollection 2020.
2
Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011-30.免疫接种预防 94 个中低收入国家 10 种病原体的投资回报:2011-2030 年。
Health Aff (Millwood). 2020 Aug;39(8):1343-1353. doi: 10.1377/hlthaff.2020.00103.
3
Upgrading Supply Chain Management Systems to Improve Availability of Medicines in Tanzania: Evaluation of Performance and Cost Effects.升级供应链管理系统以提高坦桑尼亚药品供应:绩效和成本效果评估。
Glob Health Sci Pract. 2017 Sep 28;5(3):399-411. doi: 10.9745/GHSP-D-16-00395. Print 2017 Sep 27.
4
Improving cold chain systems: Challenges and solutions.改善冷链系统:挑战与解决方案。
Vaccine. 2017 Apr 19;35(17):2217-2223. doi: 10.1016/j.vaccine.2016.08.045. Epub 2016 Sep 23.
5
Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.2011 - 2020年低收入和中等收入国家儿童免疫接种的投资回报率
Health Aff (Millwood). 2016 Feb;35(2):199-207. doi: 10.1377/hlthaff.2015.1086.
6
Costs and financing of routine immunization: Approach and selected findings of a multi-country study (EPIC).常规免疫的成本与筹资:多国研究(EPIC)的方法与部分研究结果
Vaccine. 2015 May 7;33 Suppl 1:A13-20. doi: 10.1016/j.vaccine.2014.12.066.
7
Estimating the costs of the vaccine supply chain and service delivery for selected districts in Kenya and Tanzania.估算肯尼亚和坦桑尼亚部分地区疫苗供应链及服务交付的成本。
Vaccine. 2015 May 28;33(23):2697-703. doi: 10.1016/j.vaccine.2015.03.084. Epub 2015 Apr 9.
8
How much does it cost to get a dose of vaccine to the service delivery location? Empirical evidence from Vietnam's Expanded Program on Immunization.将一剂疫苗送到服务提供地点需要多少成本?来自越南扩大免疫规划的经验证据。
Vaccine. 2014 Feb 7;32(7):834-8. doi: 10.1016/j.vaccine.2013.12.029. Epub 2013 Dec 25.
9
Impact and cost-effectiveness of Haemophilus influenzae type b conjugate vaccination in India.b 型流感嗜血杆菌结合疫苗在印度的影响和成本效益。
J Pediatr. 2013 Jul;163(1 Suppl):S60-72. doi: 10.1016/j.jpeds.2013.03.032.
10
Programme costs in the economic evaluation of health interventions.卫生干预措施经济评估中的项目成本。
Cost Eff Resour Alloc. 2003 Feb 26;1(1):1. doi: 10.1186/1478-7547-1-1.

印度电子疫苗智能网络的投资回报。

Return on investment of the electronic vaccine intelligence network in India.

机构信息

Immunization Division, Ministry of Health & Family Welfare, Government of India, New Delhi, India.

John Snow India, Immunization Technical Support Unit (ITSU), New Delhi, India.

出版信息

Hum Vaccin Immunother. 2022 Dec 31;18(1):2009289. doi: 10.1080/21645515.2021.2009289. Epub 2021 Dec 14.

DOI:10.1080/21645515.2021.2009289
PMID:34905441
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8928793/
Abstract

The electronic vaccine intelligence network (eVIN) was introduced by India's Ministry of Health and Family Welfare in 12 states and was implemented by the United Nations Development Programme through the Gavi health system strengthening support during 2014-17 to replace the traditional paper-based cold-chain management system with an electronic vaccine logistics management system. An economic assessment was conducted as part of the overall assessment of eVIN. The objective of the economic assessment was to conduct a return on investment analysis of eVIN implementation. Return on investment was defined as the ratio of total benefits (savings) from eVIN to total investment in eVIN. All costs were calculated in 2020 prices and reported in Indian rupees (1 US dollar = INR 74.132). A one-rupee investment in eVIN led to a return of INR 0.52 for traditional vaccines. The highest cost savings from eVIN was from better vaccine stock management. When same percentage of savings from the new vaccines were incorporated into the analysis, one-rupee investment in eVIN led to a return of INR 1.41. In the future, when only recurrent costs will exist, the return from eVIN will be even higher: a one-rupee investment in eVIN will yield a return of INR 2.93. The assessment of eVIN showed promising results in streamlining the vaccine flow network and ensuring equity in vaccine stock management along with good return on investment; hence, there was a rapid expansion of eVIN in all 731 districts across 36 states and union territories in the country.

摘要

电子疫苗智能网络(eVIN)由印度卫生和家庭福利部在 12 个邦推出,并由联合国开发计划署通过全球疫苗免疫联盟卫生系统加强支持在 2014-17 年期间实施,以电子疫苗物流管理系统取代传统的纸质冷链管理系统。作为 eVIN 全面评估的一部分,进行了经济评估。经济评估的目的是对 eVIN 实施进行投资回报分析。投资回报率被定义为 eVIN 实施的总收益(节省)与 eVIN 总投资的比率。所有成本均按 2020 年价格计算,并以印度卢比(1 美元=74.132 印度卢比)报告。在 eVIN 上投资 1 卢比可带来传统疫苗 0.52 卢比的回报。eVIN 最大的节省成本来自更好的疫苗库存管理。当将新疫苗的相同百分比节省纳入分析时,在 eVIN 上投资 1 卢比可带来 1.41 卢比的回报。在未来,当仅存在经常性成本时,eVIN 的回报将更高:在 eVIN 上投资 1 卢比将带来 2.93 卢比的回报。eVIN 的评估结果表明,在简化疫苗流动网络和确保疫苗库存管理公平性以及良好的投资回报方面取得了有希望的结果;因此,eVIN 在该国所有 36 个邦和联邦属地的 731 个地区迅速扩大。